Consistently, in a mouse model of Parkinson’s disease (PD), IL-10 gene therapy has been shown to elicit immunomodulation with enhanced suppression of neuroinflammation associated with dopaminergic neuron survival [46]. The gene discussed is IL10; the disease is Parkinson disease.